Studies in phlebitis. VII

In vitro and in vivo evaluation of pH- solubilized levemopamil

Paul B Myrdal, P. Simamora, Y. Surakitbanharn, Samuel H Yalkowsky

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We describe a computational model and an in vitro experiment for assessing whether or not a pH-solubilized drug has the potential to precipitate upon dilution with blood. The computational model enables an efficient means of selecting buffer concentration and pH, and the in vitro test provides a simple experimental validation. Both means of screening are applied to the formulation of the weakly basic drug levemopamil-HCl. A buffered formulation of levemopamil is chosen from the computational model and shown to be free of precipitation upon dilution in vitro and to not produce phlebitis in the rabbit ear model. In comparison, an unbuffered formulation at the same pH and drug concentration precipitates in vitro and causes significant phlebitis in vivo. The results of this study reinforce the importance of buffering parenteral formulations instead of simply adjusting the pH of the formulation.

Original languageEnglish (US)
Pages (from-to)849-852
Number of pages4
JournalJournal of Pharmaceutical Sciences
Volume84
Issue number7
DOIs
StatePublished - 1995

Fingerprint

Phlebitis
Dilution
Precipitates
Pharmaceutical Preparations
Ear
Buffers
Screening
Blood
Rabbits
emopamil
In Vitro Techniques
Experiments

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this

Studies in phlebitis. VII : In vitro and in vivo evaluation of pH- solubilized levemopamil. / Myrdal, Paul B; Simamora, P.; Surakitbanharn, Y.; Yalkowsky, Samuel H.

In: Journal of Pharmaceutical Sciences, Vol. 84, No. 7, 1995, p. 849-852.

Research output: Contribution to journalArticle

@article{d7d9545f237340d7a198698aaf367cfd,
title = "Studies in phlebitis. VII: In vitro and in vivo evaluation of pH- solubilized levemopamil",
abstract = "We describe a computational model and an in vitro experiment for assessing whether or not a pH-solubilized drug has the potential to precipitate upon dilution with blood. The computational model enables an efficient means of selecting buffer concentration and pH, and the in vitro test provides a simple experimental validation. Both means of screening are applied to the formulation of the weakly basic drug levemopamil-HCl. A buffered formulation of levemopamil is chosen from the computational model and shown to be free of precipitation upon dilution in vitro and to not produce phlebitis in the rabbit ear model. In comparison, an unbuffered formulation at the same pH and drug concentration precipitates in vitro and causes significant phlebitis in vivo. The results of this study reinforce the importance of buffering parenteral formulations instead of simply adjusting the pH of the formulation.",
author = "Myrdal, {Paul B} and P. Simamora and Y. Surakitbanharn and Yalkowsky, {Samuel H}",
year = "1995",
doi = "10.1002/jps.2600840713",
language = "English (US)",
volume = "84",
pages = "849--852",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Studies in phlebitis. VII

T2 - In vitro and in vivo evaluation of pH- solubilized levemopamil

AU - Myrdal, Paul B

AU - Simamora, P.

AU - Surakitbanharn, Y.

AU - Yalkowsky, Samuel H

PY - 1995

Y1 - 1995

N2 - We describe a computational model and an in vitro experiment for assessing whether or not a pH-solubilized drug has the potential to precipitate upon dilution with blood. The computational model enables an efficient means of selecting buffer concentration and pH, and the in vitro test provides a simple experimental validation. Both means of screening are applied to the formulation of the weakly basic drug levemopamil-HCl. A buffered formulation of levemopamil is chosen from the computational model and shown to be free of precipitation upon dilution in vitro and to not produce phlebitis in the rabbit ear model. In comparison, an unbuffered formulation at the same pH and drug concentration precipitates in vitro and causes significant phlebitis in vivo. The results of this study reinforce the importance of buffering parenteral formulations instead of simply adjusting the pH of the formulation.

AB - We describe a computational model and an in vitro experiment for assessing whether or not a pH-solubilized drug has the potential to precipitate upon dilution with blood. The computational model enables an efficient means of selecting buffer concentration and pH, and the in vitro test provides a simple experimental validation. Both means of screening are applied to the formulation of the weakly basic drug levemopamil-HCl. A buffered formulation of levemopamil is chosen from the computational model and shown to be free of precipitation upon dilution in vitro and to not produce phlebitis in the rabbit ear model. In comparison, an unbuffered formulation at the same pH and drug concentration precipitates in vitro and causes significant phlebitis in vivo. The results of this study reinforce the importance of buffering parenteral formulations instead of simply adjusting the pH of the formulation.

UR - http://www.scopus.com/inward/record.url?scp=0029040823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029040823&partnerID=8YFLogxK

U2 - 10.1002/jps.2600840713

DO - 10.1002/jps.2600840713

M3 - Article

VL - 84

SP - 849

EP - 852

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 7

ER -